Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 2
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine Vectors Harnessing the Power of Cytomegaloviruses.
Ynga-Durand MA, Dekhtiarenko I, Cicin-Sain L. Ynga-Durand MA, et al. Vaccines (Basel). 2019 Oct 17;7(4):152. doi: 10.3390/vaccines7040152. Vaccines (Basel). 2019. PMID: 31627457 Free PMC article. Review.
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.
Jacobsen H, Strengert M, Maaß H, Ynga Durand MA, Katzmarzyk M, Kessel B, Harries M, Rand U, Abassi L, Kim Y, Lüddecke T, Metzdorf K, Hernandez P, Ortmann J, Heise JK, Castell S, Gornyk D, Glöckner S, Melhorn V, Kemmling Y, Lange B, Dulovic A, Marsall P, Häring J, Junker D, Schneiderhan-Marra N, Hoffmann M, Pöhlmann S, Krause G, Cicin-Sain L. Jacobsen H, et al. Among authors: ynga durand ma. Sci Rep. 2022 Nov 18;12(1):19858. doi: 10.1038/s41598-022-22552-y. Sci Rep. 2022. PMID: 36400804 Free PMC article.
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M, Bertoglio F, Steinke S, Heine PA, Ynga-Durand MA, Maass H, Sammartino JC, Cassaniti I, Zuo F, Du L, Korn J, Milošević M, Wenzel EV, Krstanović F, Polten S, Pribanić-Matešić M, Brizić I, Baldanti F, Hammarström L, Dübel S, Šustić A, Marcotte H, Strengert M, Protić A, Piralla A, Pan-Hammarström Q, Čičin-Šain L, Hust M. Schubert M, et al. Among authors: ynga durand ma. BMC Med. 2022 Mar 3;20(1):102. doi: 10.1186/s12916-022-02312-5. BMC Med. 2022. PMID: 35236358 Free PMC article.
Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.
Azouz NP, Klingler AM, Pathre P, Besse JA, Baruch-Morgenstern NB, Ballaban AY, Osswald GA, Brusilovsky M, Habel JE, Caldwell JM, Ynga-Durand MA, Abonia PJ, Hu YC, Wen T, Rothenberg ME. Azouz NP, et al. Among authors: ynga durand ma. Sci Transl Med. 2020 May 27;12(545):eaaz7773. doi: 10.1126/scitranslmed.aaz7773. Sci Transl Med. 2020. PMID: 32461336 Free PMC article.
The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses.
Azouz NP, Ynga-Durand MA, Caldwell JM, Jain A, Rochman M, Fischesser DM, Ray LM, Bedard MC, Mingler MK, Forney C, Eilerman M, Kuhl JT, He H, Biagini Myers JM, Mukkada VA, Putnam PE, Khurana Hershey GK, Kottyan LC, Wen T, Martin LJ, Rothenberg ME. Azouz NP, et al. Among authors: ynga durand ma. Sci Transl Med. 2018 Jun 6;10(444):eaap9736. doi: 10.1126/scitranslmed.aap9736. Sci Transl Med. 2018. PMID: 29875205 Free PMC article.
Erratum to "Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome".
Alonso-Bello CD, Jiménez-Martínez MDC, Vargas-Camaño ME, Hierro-Orozco S, Ynga-Durand MA, Berrón-Ruiz L, Alcántara-Montiel JC, Santos-Argumedo L, Andrea Herrera-Sánchez D, Lozano-Patiño F, Castrejón-Vázquez MI. Alonso-Bello CD, et al. Among authors: ynga durand ma. Case Reports Immunol. 2021 Jan 31;2021:2361360. doi: 10.1155/2021/2361360. eCollection 2021. Case Reports Immunol. 2021. PMID: 33628541 Free PMC article.
Dialyzable Leukocyte Extract (Transferon™) Administration in Sepsis: Experience from a Single Referral Pediatric Intensive Care Unit.
Castrejón Vázquez MI, Reséndiz-Albor AA, Ynga-Durand MA, Arciniega Martínez IM, Orellana-Villazon VI, García López CA, Laue Noguera ML, Vargas Camaño ME. Castrejón Vázquez MI, et al. Among authors: ynga durand ma. Biomed Res Int. 2019 Jun 23;2019:8980506. doi: 10.1155/2019/8980506. eCollection 2019. Biomed Res Int. 2019. PMID: 31341910 Free PMC article.
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
Alonso-Bello CD, Jiménez-Martínez MDC, Vargas-Camaño ME, Hierro-Orozco S, Ynga-Durand MA, Berrón-Ruiz L, Alcántara-Montiel JC, Santos-Argumedo L, Herrera-Sánchez DA, Lozano-Patiño F, Castrejón-Vázquez MI. Alonso-Bello CD, et al. Among authors: ynga durand ma. Case Reports Immunol. 2019 Jul 4;2019:6357256. doi: 10.1155/2019/6357256. eCollection 2019. Case Reports Immunol. 2019. PMID: 31355024 Free PMC article.